Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 6/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.33 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.32 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25909657 | 0.78 | TAAR1 (0.41) | TAAR1LMNATSHRADRA2AADRA2C | |
| SCHEMBL25909658 | 0.78 | TAAR1 (0.41) | TAAR1LMNATSHRADRA2AADRA2C | |
| SCHEMBL15302723 | 0.78 | TAAR1 (0.33) | TDP1TAAR1LMNASLC6A2TSHR | |
| SCHEMBL12815293 | 0.78 | TSHR (0.38) | TDP1TAAR1LMNASLC6A2TSHR | |
| SCHEMBL15302680 | 0.78 | TDP1 (0.33) | TDP1TAAR1LMNASLC6A2TSHR | |
| SCHEMBL380702 | 0.77 | TDP1 (0.36) | TDP1TAAR1LMNASLC6A2TSHR | |
| SCHEMBL18726525 | 0.76 | THRB (0.38) | TDP1TAAR1LMNASLC6A2TSHR | |
| SCHEMBL8992273 | 0.74 | TDP1 (0.35) | TDP1TAAR1LMNASLC6A2TSHR | |
| Fluoride SCHEMBL27639901 | 0.74 | TDP1 (0.35) | TDP1TAAR1LMNASLC6A2TSHR | |
| SCHEMBL15915020 | 0.74 | LMNA (0.38) | TAAR1LMNASLC6A2TSHRMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230258563-A1 | DETECTION OF VOLATILES | ISOBIONICS B V (NL) | 2023-08-17 | — | — | US | claimed |
| US-5516871-A | Diphenylsiloxane oligomers functionalized at both terminals and methods for the preparation thereof | DOW CORNING ASIA, LTD. (JP) | 1996-05-14 | — | — | US | claimed |
| US-5502229-A | ENDCAPPING | DOW CORNING ASIA, LTD. (JP) | 1996-03-26 | — | — | US | claimed |
| CN-117480220-A | Antifouling paint composition and coating film | 日本油漆船舶涂料公司 | 2024-01-30 | — | — | CN | disclosed |
| EP-4299684-A1 | ANTIFOULING COATING COMPOSITION AND COATING FILM | Nippon Paint Marine Coatings Co., Ltd. (JP) | 2024-01-03 | — | — | EP | disclosed |
| EP-3693421-B1 | ANTIFOULING PAINT COMPOSITION AND COATED ARTICLE HAVING ANTIFOULING COATING FORMED USING SAID COMPOSITION ON SURFACE | NITTO KASEI CO LTD (JP) | 2023-12-20 | — | — | EP | disclosed |
| US-20230258563-A1 | DETECTION OF VOLATILES | ISOBIONICS B V (NL) | 2023-08-17 | — | — | US | disclosed |
| WO-2023277824-A2 | DIVERSE FUNCTIONALIZATION OF HYDROSILANES AND PROGRAMMABLE SYNTHESIS OF MULTISUBSTITUTED ORGANOSILANES ENABLED BY NEUTRAL EOSIN Y PHOTOCATALYSIS | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2023-01-05 | — | — | WO | disclosed |
| EP-4004538-A1 | DETECTION OF VOLATILES | Isobionics B.V. (NL) | 2022-06-01 | — | — | EP | disclosed |
| CN-111886304-B | Antifouling coating composition | 日东化成株式会社 | 2022-02-01 | — | — | CN | disclosed |
| EP-3693426-B1 | ANTIFOULING PAINT COMPOSITION AND COATED ARTICLE HAVING ANTIFOULING COATING FORMED USING SAID COMPOSITION ON SURFACE | NITTO KASEI CO LTD (JP) | 2021-12-29 | — | — | EP | disclosed |
| US-5502229-A | ENDCAPPING | DOW CORNING ASIA, LTD. (JP) | 1996-03-26 | — | — | US | disclosed |
| WO-1996008503-A1 | INTERMEDIATES FOR DINUCLEOTIDE AND OLIGONUCLEOTIDE ANALOGUES | NOVARTIS AG (CH) | 1996-03-21 | — | — | WO | disclosed |
| WO-1996007666-A1 | MONONUCLEOTIDE AND DINUCLEOTIDE ANALOGUES AND INTERMEDIATES THEREFOR | NOVARTIS AG (CH) | 1996-03-14 | — | — | WO | disclosed |
| WO-1995033761-A1 | STEROID DERIVATIVES FOR TREATMENT OF 5 ALPHA REDUCTASE | SMITHKLINE BEECHAM CORPORATION (US) | 1995-12-14 | — | — | WO | disclosed |
| US-5466677-A | Dinucleoside phosphinates and their pharmaceutical compositions | CIBA-GEIGY CORPORATION (US) | 1995-11-14 | — | — | US | disclosed |
| EP-0629633-A2 | Dinucleotide analogues, intermediates therefor and oligonucleotides derived therefrom | CIBA-GEIGY AG (CH) | 1994-12-21 | — | — | EP | disclosed |
| EP-0614906-A1 | Mononucleotide analogues and intermediates therefor | CIBA-GEIGY AG (CH) | 1994-09-14 | — | — | EP | disclosed |
| EP-0614907-A1 | Dinucleotide and oligonucleotide analogues | CIBA-GEIGY AG (CH) | 1994-09-14 | — | — | EP | disclosed |
| EP-0567271-A2 | Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses | SANKYO COMPANY LIMITED (JP) | 1993-10-27 | — | — | EP | disclosed |